FDA Tries To Shake Teva's Bid To Block Copaxone Generics

FDA Tries To Shake Teva's Bid To Block Copaxone Generics

The U.S. Food and Drug Administration on Monday urged a Washington federal judge to dismiss Teva Pharmaceutical Industries Ltd.'s suit seeking to prevent the agency from approving generic versions of its multiple sclerosis drug Copaxone without requiring ...read more

  • Tags: